These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8438284)

  • 21. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
    Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
    Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro expanded alloantigen-specific CD4+CD25+ regulatory T cell treatment for the induction of donor-specific transplantation tolerance.
    Jiang S; Golshayan D; Tsang J; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1879-82. PubMed ID: 17161340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xenogeneic (bovine) peripheral blood leukocytes engrafted into severe combined immunodeficient mice retain primary immune function.
    Greenwood JD; Croy BA; Trout DR; Wilcock BP
    Vet Immunol Immunopathol; 1997 Oct; 59(1-2):93-112. PubMed ID: 9437828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
    Valmori D; Liénard D; Waanders G; Rimoldi D; Cerottini JC; Romero P
    Cancer Res; 1997 Feb; 57(4):735-41. PubMed ID: 9044853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Bellone S; Anfossi S; O'Brien TJ; Cannon MJ; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Cancer; 2009 Feb; 115(4):800-11. PubMed ID: 19117353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alloreactivity as a source of high avidity peptide-specific human CTL.
    Münz C; Obst R; Osen W; Stevanović S; Rammensee HG
    J Immunol; 1999 Jan; 162(1):25-34. PubMed ID: 9886366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28.
    Dankers MK; Roelen DL; Van Der Meer-Prins EM; De Lange P; Korfage N; Smits JM; Persijn GG; Welsh KI; Doxiadis II; Claas FH
    Transplantation; 2003 Feb; 75(3):418-20. PubMed ID: 12589169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of CTLA-4 (CD152) enhances the murine antibody response to pneumococcal capsular polysaccharides.
    Boudewijns M; Jeurissen A; Wuyts M; Moens L; Boon L; Van Neerven JJ; Kasran A; Overbergh L; Lenaerts C; Waer M; Mathieu C; Ceuppens JL; Bossuyt X
    J Leukoc Biol; 2005 Nov; 78(5):1060-9. PubMed ID: 16081596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Human peripheral blood CD4+ T-lymphocytes reconstituting severe combined immunodeficient mouse-human cell immune system and its immunological function].
    Zeng QH; Wang W; Liu T; Shi Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):513-6. PubMed ID: 16137035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma.
    Komori H; Nakatsura T; Senju S; Yoshitake Y; Motomura Y; Ikuta Y; Fukuma D; Yokomine K; Harao M; Beppu T; Matsui M; Torigoe T; Sato N; Baba H; Nishimura Y
    Clin Cancer Res; 2006 May; 12(9):2689-97. PubMed ID: 16675560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melan-A/MART1 analog peptide triggers anti-myeloma T-cells through crossreactivity with HM1.24.
    Christensen O; Lupu A; Schmidt S; Condomines M; Belle S; Maier A; Hose D; Neuber B; Moos M; Kleist C; Terness P; Ho AD; Goldschmidt H; Klein B; Hundemer M
    J Immunother; 2009; 32(6):613-21. PubMed ID: 19483648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells.
    Dawson NA; Lamarche C; Hoeppli RE; Bergqvist P; Fung VC; McIver E; Huang Q; Gillies J; Speck M; Orban PC; Bush JW; Mojibian M; Levings MK
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30753169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice).
    Watanabe Y; Takahashi T; Okajima A; Shiokawa M; Ishii N; Katano I; Ito R; Ito M; Minegishi M; Minegishi N; Tsuchiya S; Sugamura K
    Int Immunol; 2009 Jul; 21(7):843-58. PubMed ID: 19515798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined transfection with EBV-specific epitopes and HLA-A2 genes is more effective than separate transfection in promoting CTL lysis against nasopharyngeal carcinoma.
    Ding W; Fong C
    Cell Mol Immunol; 2004 Jun; 1(3):229-34. PubMed ID: 16219173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouse.
    Pober JS; Bothwell AL; Lorber MI; McNiff JM; Schechner JS; Tellides G
    Springer Semin Immunopathol; 2003 Sep; 25(2):167-80. PubMed ID: 12955465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimeras.
    Murphy WJ; Funakoshi S; Fanslow WC; Rager HC; Taub DD; Longo DL
    Clin Immunol; 1999 Jan; 90(1):22-7. PubMed ID: 9884349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human immunoglobulins produced in hu-PBL-SCID mice are polyclonal early after xenotransplantation.
    Tissot JD; Schneider P; Schapira M; Duchosal MA
    Cell Immunol; 1996 Feb; 167(2):241-8. PubMed ID: 8603433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognition of HLA-derived peptides in transplant patients.
    Zavazava N; Stegmann S; Freese A; Müller-Ruchholtz W
    Transplant Proc; 1995 Feb; 27(1):489-90. PubMed ID: 7879072
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serology of organ transplantation].
    Mayr WR
    Wien Klin Wochenschr; 1970 Jan; 82(2):21-8 passim. PubMed ID: 4934917
    [No Abstract]   [Full Text] [Related]  

  • 40. Association between blood transfusion, HLA-DRW6, and response to dinitrochlorobenzene skin test.
    Tsakiris D; Watson MA; Degiannis D; Briggs JD; Junor BJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):705-7. PubMed ID: 3274849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.